Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma
Chemical Biology & Drug Design · 2023-11 · 102 (5) · 1097-1109
DOI: 10.1111/cbdd.14309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 28.07.2023. Verfasst von Lu Ying und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most malignant brain tumor and incurable. Medicarpin (MED), a flavonoid compound from the legume family, has multiple targets and anticancer properties. However, the role of MED in GBM remains unclear. The objective of this study was to explore the effects of MED on the apoptosis of GBM and to explain the potential molecular mechanisms. We found that the IC 50 values of U251 and U‐87 MG cells treated with MED for 24 h were 271 μg/mL and 175 μg/mL, and the IC 50 values for 48 h were 154 μg/mL and 161 μg/mL, respectively. Additionally, the cell cycle of U251 and U‐87 MG cells were arrested at the G2/M phase. Furthermore, the apoptosis rate of U251 and U‐87 MG cells increased from 6.26% to 18.36% and 12.46% to 31.33% for 48 h, respectively. The migration rate of U251 and U‐87 MG decreased from 20% to 5% and 25% to 15% for 12 h and these of U251 and U‐87 MG decreased from 50% to 28% and 60% to 25% for 24 h. MED suppressed GBM tumorigenesis, and improved survival rate of tumor‐bearing mice. Taken together, MED triggered GBM apoptosis through upregulation of pro‐apoptotic proteins (BID, BAX, CASP3, CASP8, and CYCS), showed strong inhibitory effects on cell proliferation and cell migration, and displayed anti‐tumor activity in nude mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Technology, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing, China.
- College of Life Science and Technology, Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production and Construction Corps, Tarim University, Xinjiang, China.
Zitieren
APA
Ying, L., Hao, M., Zhang, Z., Guo, R., Liang, Y., Yu, C., & Yang, Z. (2023). Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma. Chemical Biology & Drug Design, 102(5), 1097-1109. https://doi.org/10.1111/cbdd.14309
Vancouver
Ying L, Hao M, Zhang Z, Guo R, Liang Y, Yu C, et al. Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma. Chemical Biology & Drug Design. 2023;102(5):1097-1109. doi:10.1111/cbdd.14309
BibTeX
@article{Ying2023,
author = {Ying, Lu and Hao, Mingxuan and Zhang, Zichen and Guo, Rui and Liang, Youfeng and Yu, Changyuan and Yang, Zhao},
title = {Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma},
journal = {Chemical Biology & Drug Design},
year = {2023},
volume = {102},
number = {5},
pages = {1097--1109},
doi = {10.1111/cbdd.14309}
}
EUVIMED